Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma

Journal of Investigative Dermatology

Volumn 123, Issue 4, 2004, Pages 788-790

  Arbiser, Jack L ^a   Fan, Chun Yang ^b   Su, Xiaobo ^b   Van Emburgh, Beth O ^c   Cerimele, Francesca ^a   Miller, Mark Steven ^c   Harvell, Jeff ^d,e   Marinkovich, M Peter ^d,e  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinoma; Epidermolysis bullosa; Tumor suppressor

Indexed keywords

COLLAGEN TYPE 7; PROTEIN P16; PROTEIN P53;

ADULT; ANEMIA; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CANCER INVASION; CASE REPORT; CAUSE OF DEATH; DERMIS; DISEASE ASSOCIATION; EPIDERMIS; EPIDERMOLYSIS BULLOSA DYSTROPHICA; FEMALE; FIBER; FINGER; GROWTH RETARDATION; HUMAN; HUMAN TISSUE; METASTASIS; METHYLATION; MORBIDITY; MORTALITY; MUTATION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 4644350078     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.23418.x     Document Type: Article

References (26)

1. Arbiser JL, Fine JD, Murrell D, et al: Basic fibroblast growth factor: A missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa. Mol Med 4:191-195, 1998a
2. Arbiser JL: Molecular regulation of angiogenesis and tumorigenesis by signal transduction pathways: Evidence of predictable and reproducible patterns of synergy in diverse neoplasms. Semin cancer Biol 14:81-91, 2004
3. Arbiser JL, Klauber N, Rohan R, et al: Curcumin is an in vivo inhibitor of angiogenesis [in process citation]. Mol Med 4:376-383, 1998b
4. Bech-Otschir D, Kraft R, Huang X, Henklein P, Kapelari B, Pollmann C, Dubiel W: COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J 20:1630-1639, 2001
5. Cripps KJ, Purdie CA, Carder PJ, White S, Komine K, Bird CC, Wyllie AH: A study of stabilization of P53 protein versus point mutation in colorectal-carcinoma. Oncogene 9:2739-2743, 1994
6. Dittmer D, Pati S, Zambetti G, et al: Gain of function mutations in P53. Nat Genet 4:42-46, 1993
7. Elmets CA, Singh D, Tubesing K, Matsui M, Katiyar S, Mukhtar H: Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol 44:425-432, 2001
8. Esteller M, Herman JG: Generating mutations but providing chemosensitivity: The role of O-6-methylguanine DNA methyltransferase in human cancer. Oncogene 23:1-8, 2004
9. Govindarajan B, Klafter R, Miller MS, et al: Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(Ink4a) and activation of MAP kinase. Mol Med 8:1-8, 2002
10. Kalinke DU, Kalinke U, Baldi A, Winberg JO, Lauharanta J, Uitto J, Bruckner Tuderman L: Point mutations in the regions of the Col7A1 gene coding for the Nc-1 and Nc-2 domains of collagen-Vii in patients with recessive epidermolysis-bullosa-dystrophica (R-Ebd). J Invest Dermatol 103:850, 1994
11. Keefe M, Wakeel RA, Dick DC: Death from metastatic, cutaneous, squamous-cell carcinoma in autosomal recessive dystrophic epidermolysis bullosa despite permanent inpatient care. Dermatologica 177:180-184, 1988
12. Linardopoulos S, Street AJ, Quelle DE, Parry D, Peters G, Sherr CJ, Balmain A: Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors. Cancer Res 55:5168-5172, 1995
13. Martin EA, Robinson PJ, Franklin RA: Oxidative stress regulates the interaction of p16 with Cdk4. Biochem Biophys Res Commun 275:764-767, 2000
14. Marutani M, Tonoki H, Tada M, et al: Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme. Cancer Res 59:4765-4769, 1999
15. McGrath J, Ashton G, Mellerio J, et al: Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through alternative splicing of exons containing nonsense or frameshift mutations. J Invest Dermatol 112:590, 1999
16. McGrath JA, Schofield OMV, Mayou BJ, Mckee PH, Eady RAJ: Metastatic squamous-cell carcinoma resembling angiosarcoma complicating dystrophic epidermolysis-bullosa. Dermatologica 182:235-238, 1991
17. Merlo A, Herman JG, Mao L, et al: 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1:686-692, 1995
18. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P: The IARC TP53 database: New online mutation analysis and recommendations to users. Hum Mutat 19:607-614, 2002
19. Omenn GS, Goodman GE, Thornquist MD, et al: Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150-1155, 1996
20. Rosas SL, Koch W, da Costa Carvalho ME, Wu L, Califano J, Westra W, Jen J, Sidransky D: Promoter hypermethylation patterns of p1606-methylguanine-DNA- methytransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 61:939-942, 2001
21. Reed WB, Roenigk H, Dorner W, Welsh O, Martin FJO: Epidermal neoplasms with epidermolysis bullosa dystrophica with first report of carcinoma with acquired type. Arch Dermatol Forsch 253:1-14, 1975
22. Sanchez-Cespedes M, Esteller M, Wu L, et al: Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 60:892-895, 2000
23. Smoller BA, McNutt NS, Carter DM, Gottlieb AB, Hsu A, Krueger J: Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis. Arch Dermatol 126:78-83, 1990
24. Tyler LN, Ai LB, Zuo CL, Fan CY, Smoller BR: Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin. Mod Pathol 16:660-664, 2003
25. Wolf P, Hu YC, Doffek K, Sidransky D, Ahrendt SA: O-6-methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer. Cancer Res 61:8113-8117, 2001
26. Ziegler A, Leffell DJ, Kunala S, et al: Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 90:4216-4220, 1993